ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/6/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
(NASDAQ: SPRY) Delayed: 5.62 -0.05 (0.88%)
Previous Close $5.67    52 Week High $ 
Open $5.60    52 Week Low $ 
Day High $5.70    P/E N/A 
Day Low $5.54    EPS $ 
Volume 852,563